Fredun Pharmaceuticals Acquires 26% Stake In Goodman Vetcare For ₹300 Crore
Mumbai: Fredun Pharmaceuticals Limited announced on 8 October 2026, it has acquired a 26% stake in Goodman Vetcare Private Limited for ₹300 crore. Goodman Vetcare, a pet pharmacy chain, plans to open eight new stores across three cities. Pet Care Ecosystem Expansion The acquisition of Goodman Vetcare positions Fredun Pharmaceuticals in the veterinary retail market. Goodman Vetcare aims for a…
Mumbai, October 8, 2026 - Fredun Pharmaceuticals Limited announced on October 8, 2026, the acquisition of a 26% stake in Goodman Vetcare Private Limited for ₹300 crore. Goodman Vetcare is a pet pharmacy chain that intends to establish eight new stores in three cities. This acquisition solidifies Fredun Pharmaceuticals' presence in the veterinary retail sector.
Goodman Vetcare aims to generate approximately ₹100 crore in revenue by the end of FY31. In addition to this stake, Fredun Pharmaceuticals has also acquired Furlicks, an oral-strip pet-wellness brand. The company plans to launch 16 new products within the next 6-9 months, expanding its product portfolio from 6 SKUs to 22 SKUs. Fredun is also developing WAGR, a technology-driven pet-parenting platform.
The company's strategy involves shifting from an OEM-led business model to a 100% branded portfolio by 2029, aiming for a doubling of revenue and profitability over the next 3-4 years. To support this growth, Fredun is investing in expanding its manufacturing capacity. A 40,000 sq ft utility block in Palghar is set to become operational in October 2026, while a further 50,000 sq ft is planned as part of the company's aim to build a large single-location pharma plant in India.
On July 17, 2026, Fredun allotted 1.10 crore bonus equity shares, raising its equity share base from 55.13 lakh to 1.65 crore shares. In September 2026, an additional 3,61,599 equity shares were issued following the conversion of warrants held by non-promoter investors. This information is based on company exchange filings and is provided for informational purposes only. Investors are advised to conduct their own risk assessments before making any investment decisions.
Rewritten by urgent.news; may contain errors — check the original.
Source: freepressjournal.in